Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Radiographic Outcomes After Flapless Approach of Intrabony Defects With the Application of Enamel Matrix Derivative Versus Hyaluronic Acid: A Randomized Controlled Clinical Trial

NCT07339605 is registered in ClinicalTrials.gov with University of Valencia as lead sponsor.

NCT NCT07339605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07339605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Radiographic Outcomes After Flapless Approach of Intrabony Defects With the Application of Enamel Matrix Derivative Versus Hyaluronic Acid: A Randomized Controlled Clinical Trial
Lead sponsor
University of Valencia
Phase
Not applicable
Overall status
Recruiting
Start date
October 26, 2024
Completion date
July 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar bone loss* / therapy, dental enamel proteins* / therapeutic use, flapless, guided tissue regeneration, periodontal / methods, humans, hyaluronic acid* / therapeutic use, intrabony defect